TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Moxifloxacin not superior to ethambutol for recurrent TB

Despite reducing the median time to culture conversion, replacing ethambutol with moxifloxacin has not shown efficacy in recurrent tuberculosis treatment success in an 8-week trial, according to a study published in Clinical Infectious Diseases.

Read the full story at Infectious Disease Advisor.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Infectious Disease Advisor

Published: March 29, 2019, 11:31 p.m.

Last updated: Nov. 14, 2024, 7:43 p.m.

Tags: Treatment

Print Share